The National Institute of Health Research (NIHR) awarded \u00a34 million to enable state-of-the-art psychological therapy to be delivered via virtual reality (VR) in the NHS, in a project that brings together a team of NHS trusts, universities, a mental health charity, the Royal College of Art, and a University of Oxford spin-out company.
Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured \u00a320 million in Series A financing.
The University of Oxford, Oxford University Hospitals NHS Foundation Trust and the Patient experience healthcare company Oneview Healthcare have signed a research and development (R&D) agreement for clinical pathways, following the success of a Prostate Cancer Pathway pilot.
The \u00a313m drug discovery partnership between Oxford University, Oxford Sciences Innovation and Evotec supported 12 new projects in first year of operation.
A new paper published today by the Oxford Martin School calls for \u2018open science\u2019 approaches to drug discovery and offers ways forward that would transform how the medical challenges of this century could be addressed more efficiently.
Sociologist Alex Rushforth (Nuffield Department of Primary Care Health Sciences), recently attended Oxford\u2019s annual digital health pitching event, The Hill, for the first time. Here\u2019s what he made of it.
The 2017 Oxford University iGEM team have just returned from the competition in Boston with not only a Gold medal but also the extremely competitive award for Best Diagnostics Project in the Undergraduate category. In addition they were nominated for five further awards for best presentation, wiki, model, integrated human practices and best applied design.
Modified silk from Asian wild silkworms could be used in a strategy to repair damaged spinal cords, according to scientists from the universities of Aberdeen and Oxford.
A new approach to targeting key cancer-linked proteins, thought to be \u2018undruggable\u2019, has been discovered through an alliance between industry and academia.
Researchers from Oxford have been using virtual reality software to compile genetic data to create models which explain how genes are controlled within their natural chromosomal environments.
The UK is in the midst of a wide-ranging national industrial strategy which will influence the country\u2019s future role in the global economy. The latest proposals look at the life sciences and healthcare sectors, perhaps the areas of this grand plan which will affect most people, including through the successful development \u2013 or otherwise \u2013 of the National Health Service.
A group of respiratory medicine experts have called for an overhaul in our thinking about how asthma and other airways diseases are categorised and treated, saying the current approach is outdated and does not reflect advances in treating these conditions.
![\"\"](\"https://www.medsci.ox.ac.uk/news/nhs-mental-health-services-to-offer-virtual-reality-treatment/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n